With the growing global demand for biopharmaceuticals, service providers that offer critical processes, scalability, and raw material supply for biopharmaceutical development play a vital role. Avantor is one such provider, offering key products and services to clients in the global life sciences, advanced technology, and applied materials industries. Tangneng Translation established a translation partnership with Avantor in June this year, focusing on legal documents, product promotional materials, and other content.
Founded in 1904, Avantor provides a range of products and services to meet the production and research needs of clients in biotechnology, pharmaceuticals, medical devices, diagnostics, aerospace and defense, and semiconductors. As a Fortune 500 company, Avantor has a commercial footprint spanning three continents, operating in over 30 countries with more than 200 manufacturing, distribution, and sales centers worldwide. It went public on the New York Stock Exchange in May 2019 under the ticker symbol AVTR.
In 2010, Avantor introduced its global expertise to China, a strategically critical market. Since then, it has been dedicated to deepening its presence in China and driving new breakthroughs in the biopharmaceutical industry. It offers on-site services, procurement services, equipment management services, clinical services, and digital solutions to the Chinese market. To date, Avantor has established 9 warehouses and 4 offices in China, serving over 1,100 clients.
Throughout the lengthy process of drug research, development, and launch, Avantor's standardized management and industry-leading overall quality solutions help clients at different stages of development explore basic research, improve preparation processes, and enhance production efficiency. As a leading translation service provider in the pharmaceutical and medical industry, Tangneng Translation has long maintained good cooperative relationships with major biopharmaceutical and medical device companies, such as Junshi Biosciences, Qilu Pharmaceutical, East China Pharmaceutical, Shangyao Bokang, Shijiazhuang Pharmaceutical Group, Shengsang Bio, BGI, and Sami Medical.
In future collaborations with Avantor, Tangneng Translation will continue to improve its service quality, ensure the smooth progress of translation projects, and assist clients in their international development journey.
